Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Paris

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The AAPS Journal|April 7, 2026
Predicting Aberrant Fc-fusion Protein Pharmacokinetics from In Silico Structural Properties and Physiologically Based Pharmacokinetic (PBPK) ModelingDanilo Tomasoni, Alessio Paris, Roberto Visintainer, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
Communications Biology|September 2, 2021
QSPcc reduces bottlenecks in computational model simulationsDanilo Tomasoni, Alessio Paris, Stefano Giampiccolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 11, 2022
An age-dependent mathematical model of neurofilament trafficking in healthy conditionsAlessio Paris, Pranami Bora, Silvia Parolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2022
A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersenAlessio Paris, Pranami Bora, Silvia Parolo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The AAPS Journal|April 7, 2026
Predicting Aberrant Fc-fusion Protein Pharmacokinetics from In Silico Structural Properties and Physiologically Based Pharmacokinetic (PBPK) ModelingDanilo Tomasoni, Alessio Paris, Roberto Visintainer, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
Communications Biology|September 2, 2021
QSPcc reduces bottlenecks in computational model simulationsDanilo Tomasoni, Alessio Paris, Stefano Giampiccolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 11, 2022
An age-dependent mathematical model of neurofilament trafficking in healthy conditionsAlessio Paris, Pranami Bora, Silvia Parolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2022
A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersenAlessio Paris, Pranami Bora, Silvia Parolo, et al.
Pageof 1